Rizatriptan benzoateProduct ingredient for Rizatriptan

Name
Rizatriptan benzoate
Drug Entry
Rizatriptan

Rizatriptan is a second-generation triptan 3 and a selective 5-HT1B and 5-HT1D receptor agonist.9 Used in the treatment of migraines, rizatriptan was first approved in the US in 1998.9 Rizatriptan is available in oral tablets, orally disintegrating tablets (wafers), and oral film formulations.

Accession Number
DBSALT001798
Structure
Synonyms
Not Available
External IDs
MK-0462